Humanpharmakologisches Zentrum Biberach
Biberach, 88397, Germany
NCT Number: NCT07774325
The main objective of this trial is to investigate the effects of multiple doses of Itraconazole and multiple doses of Ciclosporin on the pharmacokinetics of BI 3000202 in plasma following a single oral dose in healthy male trial participants.
Trial opening soon.
Get Notified18 year–55 year
Male
Interventional
Phase 1
Biberach, 88397, Germany
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
BI 3000202
Ciclosporin
Itraconazole
Time frame: up to 4 days
Time frame: up to 4 days
Time frame: up to 4 days
Contact information is provided by the study sponsor or research team.
Boehringer Ingelheim
Industry
The Effects of P-gp Inhibition and OATP Inhibition on the Pharmacokinetics of a Single Oral Dose of BI 3000202 in Healthy Male Trial Participants (an Open-label, Three-period, Two-sequence Crossover Trial, With Period 3 as Fixed Treatment)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07708493
Healthy
View Trial DetailsNCT07768813
Body Weight, Healthy
Mannheim, Germany
View Trial DetailsNCT07767487
Healthy
Anaheim, California, United States
View Trial DetailsNCT07765199
Arterial Puncture, Cardiovascular Diseases
Orléans, France
View Trial Details